National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...

UiPath Inc. (NYSE:PATH) is one of the AI stocks under $20 to buy now. On December 9, Morgan Stanley analyst Sanjit Singh raised the firm’s price target on UiPath to $19 from $15 with an Equal Weight ...

What To Know: After the market close on Tuesday, S&P Dow Jones Indices announced that agentic automation company UiPath will replace Synovus Financial Corp (NYSE: SNV) in the S&P MidCap 400, effective ...

UiPath Inc. (PATH) is one of a bunch of software companies that went public in 2021, saw its shares subsequently collapse, and have seemingly never managed to make a recovery. And to be fair, many of ...

UiPath (PATH) posted its first GAAP profit with $13M in operating income on $411M revenue. UiPath achieved an 83% gross margin. Palantir (PLTR) grew revenue 63% to $1.18B with U.S. commercial revenue ...

There's a lot of speculation right now about whether enterprise AI investments are actually delivering returns. Against the backdrop of the constantly-referenced MIT survey, UiPath just posted its ...

UiPath offers an AI-driven automation platform, targeting workflow efficiency and accessibility for a broad range of users. PATH is undervalued, trading at a forward P/E of 22, an 11% discount to the ...

There may be no enterprise job today that can’t be enhanced through the use of automation and AI, and agentic AI represents the next step toward fully realizing that potential. So says Daniel Dines, ...

UiPath isn't just riding the AI wave -- it's quietly building the infrastructure beneath it. To get there, UiPath is positioning itself around three strategic pillars: expanding automation ...

UiPath stock surged more than 40% this week following a new collaboration with ChatGPT maker OpenAI on agentic AI technology. The rally actually started last week when UiPath announced integrations ...

Our Methods Groups provide policy advice and focus on developing the methods used to produce Cochrane reviews. Over the past year they’ve been working hard on activities from writing papers on ...

UiPath Inc. raised its full-year revenue outlook after cruising past Wall Street’s expectations and swinging to a profit in its latest quarterly results, powered by momentum in its artificial ...